The FDA ensures generic drugs are as safe and effective as brand-name drugs through the ANDA pathway. With over 90% of U.S. prescriptions filled with generics, this system saves billions annually while maintaining strict scientific standards.
Read More
The FDA's 2023-2025 changes to generic drug approvals prioritize U.S. manufacturing to fix drug shortages. Learn how the ANDA pilot program works, which drugs are affected, and what it means for prices and availability.
Read More